Vedrop tocofersolan regulatory update

EMEA's CHMP issued a negative opinion on an MAA from Recordati for Vedrop tocofersolan to treat vitamin E deficiency in children with chronic cholestasis or cystic fibrosis. In its decision, the agenc...